Literature DB >> 19392846

The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma.

H-L Zhang1, L-Q Chen, R-L Liu, Y-T Shi, M He, X-L Meng, S-X Bai, Y-M Ping.   

Abstract

To study the influence of the number of metastatic lymph nodes (LNs) on survival and International Union Against Cancer tumor-node-metastasis (TNM) classification for esophageal carcinoma. The clinicopathological data on 1146 patients with esophageal squamous cell carcinoma who had undergone an esophagectomy were retrospectively studied. Survival was analyzed by the Kaplan-Meier method. By subclassifying the nodes (N) category according to the number of metastatic LNs as: N0 for no LN metastases; N1(1) for only one positive node; and N1(2) for >or=2 positive nodes. TNM staging was refined as stage IIa (T2-3N0M0), stage IIb (T1N1M0 and T2N1(1)M0), stage IIIa (T2N1(2)M0 and T3N1(1)M0), and stage IIIb (T3N1(2)M0 and T4NanyM0), and the survival was analyzed. LN metastases was found in 380 of 1146 (33.2%) treated esophageal cancer patients. In 4270 LNs harvested, metastases was detected in 807 (18.9%). The 5-year survival rates of the patients with 0, 1, and >or=2 positive nodes were 59.8, 33.4, and 9.4%, respectively. There was statistically significant difference among these three groups. The 5-year survival of the patients in stages T2N1M0 and T3N1M0 was significantly higher in the N1(1) group than in the N1(2) group (41.5 vs 24.1%, and 31.2 vs 6.8%, P<0.001). The 5-year survival rates of the patients in refined stage IIa, IIb, IIIa, and IIIb were 57.1, 42.2, 28.6, and 8.5%, with significant difference existing in each stage groups. The number of positive LNs significantly influenced survival of the patients with esophageal cancer. Three grade classification (0, 1, >or=2 positive nodes) could quite well demonstrate the effect of the number of LN metastases and the survival. The refined TNM classification based on the number of LN metastases could better reflect the prognosis of esophageal cancer. Our results offer a strong rationale for refining the International Union Against Cancer TNM classification for esophageal carcinoma.

Entities:  

Mesh:

Year:  2009        PMID: 19392846     DOI: 10.1111/j.1442-2050.2009.00971.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  25 in total

Review 1.  Multi-modality therapy for cancer of the esophagus and GE junction.

Authors:  Mohamedtaki A Tejani; Barbara A Burtness
Journal:  Curr Treat Options Oncol       Date:  2012-09

Review 2.  The significance of lymph node status as a prognostic factor for esophageal cancer.

Authors:  Yasunori Akutsu; Hisahiro Matsubara
Journal:  Surg Today       Date:  2011-08-26       Impact factor: 2.549

Review 3.  Chinese expert consensus on mediastinal lymph node dissection in esophagectomy for esophageal cancer (2017 edition).

Authors:  Hui Li; Wentao Fang; Zhentao Yu; Yousheng Mao; Longqi Chen; Jie He; Tiehua Rong; Chun Chen; Haiquan Chen; Keneng Chen; Ming Du; Yongtao Han; Jian Hu; Jianhua Fu; Xiaobin Hou; Taiqian Gong; Yin Li; Junfeng Liu; Shuoyan Liu; Lijie Tan; Hui Tian; Qun Wang; Jiaqing Xiang; Meiqing Xu; Xin Ye; Bin You; Renquan Zhang; Yan Zhao
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

4.  Radiomics nomogram outperforms size criteria in discriminating lymph node metastasis in resectable esophageal squamous cell carcinoma.

Authors:  Xianzheng Tan; Zelan Ma; Lifen Yan; Weitao Ye; Zaiyi Liu; Changhong Liang
Journal:  Eur Radiol       Date:  2018-06-19       Impact factor: 5.315

5.  Overexpression of AKIP1 promotes angiogenesis and lymphangiogenesis in human esophageal squamous cell carcinoma.

Authors:  C Lin; L Song; A Liu; H Gong; X Lin; J Wu; M Li; J Li
Journal:  Oncogene       Date:  2014-01-13       Impact factor: 9.867

6.  Prognostic value of the number of lymph nodes resected in patients with lymph-node-negative esophageal squamous cell carcinoma.

Authors:  Guoping Xu; Ming Jin; Yingjie Shao; Yuan Chen; Zhonghua Ning
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

7.  Improving CT detection sensitivity for nodal metastases in oesophageal cancer with combination of smaller size and lymph node axial ratio.

Authors:  Jianfang Liu; Zhu Wang; Huafei Shao; Dong Qu; Jian Liu; Libo Yao
Journal:  Eur Radiol       Date:  2017-07-04       Impact factor: 5.315

8.  The N-classification for esophageal cancer staging: should it be based on number, distance, or extent of the lymph node metastasis?

Authors:  Qi-Rong Xu; Xue-Peng Zhuge; He-Lin Zhang; Yu-Min Ping; Long-Qi Chen
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

Review 9.  Lymph node dissection for esophageal cancer.

Authors:  Yasunori Akutsu; Hisahiro Matsubara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-03-26

10.  Aggressive surgical resection does not improve survival in operable esophageal squamous cell carcinoma with N2-3 status.

Authors:  Yu-Zhen Zheng; Wei Zhao; Yi Hu; Xiao-Xiao Ding-Lin; Jing Wen; Hong Yang; Qian-Wen Liu; Kong-Jia Luo; Qing-Yuan Huang; Jun-Ying Chen; Jian-Hua Fu
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.